FDC-SP Inhibitors
FDC-SP inhibitors, also known as Formyl Peptide Receptor 2 (FPR2) or Lipoxin A4 receptor antagonists, belong to a distinct class of chemical compounds designed to modulate the activity of the FPR2 receptor, which is a G protein-coupled receptor (GPCR) found primarily on the surface of various immune and inflammatory cells. These inhibitors are small organic molecules designed to interfere with the binding of specific ligands, such as the anti-inflammatory lipid mediator Lipoxin A4, to the FPR2 receptor. By doing so, they exert regulatory control over the downstream signaling pathways triggered by receptor activation.
Chemically, FDC-SP inhibitors are typically characterized by their unique structural features, which enable them to interact selectively with the FPR2 receptor and block its activation. Their mechanisms of action involve competitive binding to the receptor's ligand-binding site or other allosteric sites, preventing the receptor from responding to endogenous signaling molecules. These inhibitors play a pivotal role in deciphering the complex signaling cascades associated with FPR2 activation, shedding light on the intricacies of immune responses and inflammation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lopinavir | 192725-17-0 | sc-207831 | 10 mg | $132.00 | 6 | |
Lopinavir inhibits the HIV protease enzyme, preventing the cleavage of viral polyproteins into functional proteins, thus inhibiting the maturation | ||||||
Ritonavir | 155213-67-5 | sc-208310 | 10 mg | $124.00 | 7 | |
Ritonavir, often used in combination with lopinavir, also inhibits HIV protease, but it is used primarily to boost the plasma levels of lopinavir, enhancing efficacy. | ||||||
Oseltamivir | 196618-13-0 | sc-507283 | 100 g | $324.00 | ||
Oseltamivir inhibits the enzyme, preventing the release of new virus particles from infected cells and limiting the spread of the virus within the host. | ||||||
Zanamivir | 139110-80-8 | sc-208495 | 1 mg | $270.00 | 6 | |
Zanamivir, like oseltamivir, inhibits the neuraminidase enzyme, interfering with the release of virus particles from infected cells and reducing viral spread. | ||||||
Ribavirin | 36791-04-5 | sc-203238 sc-203238A sc-203238B | 10 mg 100 mg 5 g | $63.00 $110.00 $214.00 | 1 | |
Ribavirin is a guanosine analog that inhibits viral RNA synthesis by causing errors in RNA replication and interfering with the replication of various RNA and DNA, including HCV. | ||||||
Sofosbuvir | 1190307-88-0 | sc-482362 | 25 mg | $146.00 | 1 | |
Sofosbuvir is a nucleotide analog inhibitor of the HCV RNA-dependent RNA polymerase, NS5B, which is essential for viral RNA replication. It incorporates into the growing RNA chain and terminates synthesis. | ||||||
Daclatasvir | 1009119-64-5 | sc-500663 | 100 mg | $330.00 | ||
Daclatasvir is an NS5A inhibitor for HCV that disrupts thus reducing viral load by interfering with the association of NS5A with viral RNA. | ||||||